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Abstract Numerous sperm functions including the acrosome
reaction (AR) are associated with Ca2+ in£ux through vol-
tage-gated Ca2+ (CaV) channels. Although the electrophysiolog-
ical characterization of Ca2+ currents in mature sperm has prov-
en di⁄cult, functional studies have revealed the presence of low-
threshold (CaV3) channels in spermatogenic cells. However, the
molecular identity of these proteins remains unde¢ned. Here, we
identi¢ed by reverse transcription polymerase chain reaction the
expression of CaV3.3 mRNA in mouse male germ cells, an iso-
form not previously described in these cells. Immunoconfocal
microscopy revealed the presence of the three CaV3 channel
isoforms in mouse spermatogenic cells. In mature mouse sperm
only CaV3.1 and CaV3.2 were detected in the head, suggesting
its participation in the AR. CaV3.1 and CaV3.3 were found in
the principal and the midpiece of the £agella. All CaV3 channels
are also present in human sperm, but only to a minor extent in
the head. These ¢ndings were corroborated by immunogold
transmission electron microscopy. Tail localization of CaV3
channels suggested they may participate in motility, however,
mibefradil and gossypol concentrations that inhibit CaV3 chan-
nels did not signi¢cantly a¡ect human sperm motility. Only
higher mibefradil doses that can block high-threshold (HVA)
CaV channels caused small but signi¢cant motility alterations.
Antibodies to HVA channels detected CaV1.3 and CaV2.3 in
human sperm £agella.
/ 2004 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Sperm motility, capacitation and the acrosome reaction
(AR) are fundamental processes for fertilization [1^4]. The
e¡ects of certain physiological agonists of these processes
are mediated by changes in the intracellular concentration
of Ca2þ ([Ca2þ]i) [1^5]. In particular, the mouse AR is asso-
ciated with a zona pellucida-induced fast transient [Ca2þ]i in-
crease (V250 ms) involving the activation of low-threshold
activated (LVA or T-type) Ca2þ channels which is followed by
a sustained increase lasting minutes that is linked to store-
operated channel (SOC) opening [6]. In spite of the crucial
role of LVA channels in sperm physiology [3,7,8], their de¢n-
itive molecular identi¢cation and localization remains elusive.
This issue is further complicated by reports indicating that
high-threshold activated (HVA) channels are also present
and functional in mammalian spermatogenic cells and mature
sperm [9].
The inability of sperm to synthesize proteins impedes the
use of standard molecular approaches. Their minute size,
complex geometry and motile nature have precluded a system-
atic electrophysiological characterization. For these reasons,
more recent e¡orts have focused on the germ-line cells, the
progenitors of sperm [3,7,8]. Three di¡erent classes of LVA
Ca2þ channels (known as CaV3.1^CaV3.3) have been cloned
and expressed [10^12]. The presence of mRNAs for CaV3.1
and CaV3.2, but not for CaV3.3, has been previously docu-
mented in mouse [13,14] and human [15] spermatogenic cells.
None of these channels has been immunolocalized in sperm.
Very recently, using reverse transcription polymerase chain
reaction (RT-PCR) the expression of the mRNAs for all
CaV3 channels in motile human sperm was detected [16].
Here, we report the detection of a transcript for CaV3.3
from mouse male germ cells and the distribution of the di¡er-
ent low-threshold Ca2þ channel proteins in mouse spermato-
genic cells and mature mouse and human sperm. Consistent
with the expression of di¡erent low-threshold Ca2þ channel
proteins, Ni2þ inhibition of whole-cell patch-clamp native cur-
rents in mouse spermatogenic cells unveiled the presence of
subtypes of CaV3 channels in these cells.
Lastly, since CaV3.2 and CaV3.3 channels are expressed
prominently in sperm £agella, studies were carried out to ex-
plore their involvement in motility. Although gossypol had
previously been shown to inhibit motility in human sperm
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[17], our results using computer-assisted sperm motility anal-
ysis (CASA) showed that concentrations of mibefradil [11]
and gossypol [18] that inhibit low-threshold Ca2þ channels
in mouse spermatogenic cells did not reduce basal motility.
Other Ca2þ-permeable channels like Catsper and SOCs have
been shown to modulate this important function [19^21].
Higher mibefradil concentrations that can block L-type
HVA channels inhibited sperm motility and antibodies to
HVA channels detected CaV1.2 and CaV2.3 in human sperm
£agella. However, other blockers of L-type channels such as
nifedipine and calciseptine did not signi¢cantly a¡ect sperm
basal motility.
2. Materials and methods
2.1. RT-PCR
The isolation of RNA from mouse spermatogenic cells, preparation
of cDNA and RT-PCR were conducted as described previously
[22,23]. The PCR primers employed were: sense 5P-ATCTGCTCCC-
TGTCGG-3P and antisense 5P-GAGAACTGGGTCGCTATG-3P. The
conditions employed were as follows: after an initial treatment for
5 min at 94‡C, the following cycle was repeated 40 times: 30 s at
94‡C, 1 min at 54‡C, and 1 min at 72‡C. Final extension was 5 min
at 72‡C. cDNA fragments ampli¢ed by PCR were analyzed in a 1%
agarose gel; the expected size for the PCR product corresponding to
CaV3.3 was 404 bp.
2.2. Immunolocalization of Ca2+ channels in spermatogenic cells and
sperm
2.2.1. Controls (not shown). HEK-293 cells stably expressing K1G
(CaV3.1), K1H (CaV3.2) and K1I (CaV3.3) channels [24] were used to
determine the speci¢city of the primary antibodies (anti-CaV3.1,
CaV3.2 and CaV3.3 from Santa Cruz Biotechnology, and anti-
CaV3.1 from Alomone Labs). Anti-CaV3.2 and anti-CaV3.3 gave quite
speci¢c signals that were competed by the corresponding antigen in
the cells expressing the matching channel isoform. Anti-CaV3.1 from
Santa Cruz had some cross reaction with CaV3.3 and was competed
by its corresponding antigen in HEK-293 cells expressing CaV3.1 or
CaV3.3. Anti-CaV3.1 from Alomone was speci¢c for HEK-293 cells
expressing CaV3.1. In addition, the speci¢city of the antibodies was
evaluated in mouse and human sperm using antibodies preadsorbed
with the synthetic antigenic peptides (1:2^1:8 antibody:peptide ra-
tios). In human sperm antibodies were further tested for speci¢city
by showing that only the corresponding peptide antigen, and not the
others, competed antibody binding.
2.2.2. Spermatogenic cells. Aliquots of mouse spermatogenic cells
were obtained and processed as described previously [22,23]. After
¢xation with 5% paraformaldehyde and permeabilization with 0.1%
Triton X-100, cells were incubated overnight with primary T-type
Ca2þ channel polyclonal antibodies (1:100 dilution) and then for 1 h
with Alexa 594-conjugated secondary antibodies (1:100; Molecular
Probes).
2.2.3. Mouse sperm. Cells were collected from CD1 mouse epidi-
dymis. Sperm were separated into two groups: (i) non-capacitated,
handling cells in non-capacitating medium (Medium 199 without bo-
vine serum albumin, HCO33 and Ca
2þ), and (ii) acrosome-reacted,
where sperm after capacitation (30 min at 37‡C in capacitating me-
dium) were incubated with the Ca2þ ionophore A23187 (15 WM).
Aliquots of these cells were ¢xed with 5% paraformaldehyde, permea-
bilized with 0.1% Triton X-100 and incubated overnight at 4‡C with
primary antibodies at 1:100 dilution. Lastly, samples were incubated
for 1 h with the Alexa 594-conjugated antibody (1:100). Images were
acquired in a confocal microscope using Comos 7.0 and analyzed
using Confocal Assistant software 4.02 (Bio-Rad Microscience).
2.2.4. Human sperm. Semen was obtained from normal, fertile
volunteers by masturbation after at least 2 days of abstinence. Sam-
ples were subjected to swim-up preparation (see below) and used for
indirect immuno£uorescence analysis as described above for mouse
sperm. Control experiments were also processed as indicated for
mouse samples (corresponding peptides at 1:4, 1:2 and 1:8 ratios
were used for anti-CaV3.1, CaV3.2 and CaV3.3, respectively). HVA
channel antibodies against CaV1.2, CaV1.3, CaV2.1, CaV2.2, and
CaV2.3 were from Alomone Labs, and they were diluted 1:100 (cor-
responding peptides were used at 1:2 ratio, except for the CaV1.3
peptide that was used at 1:4).
2.2.5. Immunogold transmission electron microscopy. Human
sperm were ¢xed in a 4% paraformaldehyde^0.5% glutaraldehyde so-
lution in 100 WM cacodylate bu¡er (pH 7.3) for 2 h and stored until
processed. Cells were dehydrated in 20% ethanol for 20 min and then
in 40^100% ethanol. The ¢nal pellet was embedded in LR-White resin
for 5 days at 50‡C. Ultrathin sections were mounted on nickel grids.
Samples were ¢rst incubated in a blocking solution containing 10%
fetal bovine serum (FBS) and 0.005% Tween 20, and then incubated
overnight with CaV3 channel primary antibodies diluted 1:25 in phos-
phate-bu¡ered saline^3% FBS. Subsequently, samples were incubated
for 1 h with a rabbit anti-goat IgG secondary antibody (1:30) con-
jugated to 10 nm colloidal gold particles (Sigma). The sections were
counterstained with uranyl acetate and lead citrate and then examined
using a Jeol 100SX electron microscope.
2.3. Electrophysiology
Ca2þ currents were recorded in spermatogenic cells using the whole-
cell con¢guration of the patch-clamp technique as described previ-
ously [13]. Brie£y, cells were bathed in a solution containing (in
mM): CaCl2 10; NaCl 130; KCl 3; MgCl2 2; NaHCO3 1; NaH2PO4
0.5; HEPES 5; glucose 10 (pH 7.3). The internal solution consisted of
(mM): CsMeSO3 110; CsF 10; CsCl 15; CaCl2 4.6; EGTA 10;
HEPES 5; ATP-Mg2 4; phosphocreatine 10 (pH 7.3). Currents were
sampled at 10 kHz and recorded (following ¢ltering 5 kHz) by a
patch-clamp ampli¢er (Axopatch 200A; Axon Instruments) interfaced
to a personal computer via an A-to-D board (DigiData 1200A; Axon)
using computer-driven software (pCLAMP 6.0.3; Axon). Capacity
transients were electronically compensated, and linear leak and resid-
ual capacity currents were subtracted on-line using a P/4 protocol.
2.4. Evaluation of human sperm motility
After liquefaction, 1 ml of Ham’s F-10 was applied to 1 ml of
semen to allow the motile sperm to swim up into the upper layer of
the suspension (1 h at 37‡C). Swim-up sperm were collected, adjusted
to 8^12U106 cells/ml and their motility determined as previously de-
scribed [19]. For each sample,V1000 motile sperm were tracked and
analyzed with the Hamilton-Thorne HTM-IVOS-12 CASA system.
Sperm motility parameters measured included progressive velocity
(VSL), path velocity (VAP), and curvilinear velocity (VCL), as well
as amplitude of lateral head displacement (ALH), beat cross fre-
quency (BCF), linearity (LIN=VSL/VCLU100%) and straightness
(STR=VSL/VAPU100%). Ca2þ channel antagonists were prepared
as 100 mM stock solutions in deionized water (mibefradil and calci-
septine) or dimethylsulfoxide (gossypol and nifedipine).
3. Results and discussion
Mouse spermatogenic cells functionally express mainly T-
type currents, and RT-PCR studies have indicated the expres-
sion of two di¡erent genes encoding T-type channels (CaV3.1
and CaV3.2) in both mouse and human male germ cells [13^
15]. However, the expression of the third member of the CaV3
family had not been determined. Our PCR experiments using
speci¢c primers generated a band of 404 bp, which was con-
¢rmed by sequencing to be a fragment of the mouse CaV3.3
channel (Fig. 1A). The RNA expression of this isoform had
been shown to be restricted to the brain [12,25], but recently
its presence was also found in human ejaculates [16].
Given that mRNAs for the three T-type Ca2þ channels are
present in mouse spermatogenic cells, it became necessary to
establish whether the proteins are also expressed in these cells
and in mature sperm. To this end, speci¢c polyclonal anti-
bodies against both N- and C-terminal sequences of CaV3
channels were used. Most of the results shown in both imma-
ture germ cells and mature sperm were obtained with anti-
bodies against the C-terminus, however qualitatively similar
¢ndings were observed with the N-terminus antibodies. Con-
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focal immunoimages of spermatogenic cells incubated with
anti-CaV3 antibodies revealed a punctate pattern of £uores-
cence possibly indicating clusters of channels at the plasma
membrane, or intracellular accumulation of channel protein
(Fig. 1B). The strongest signal was observed with the CaV3.1
antibody (Fig. 1Ba). Nuclei, shown in green due to staining
with SYTOX Green, excluded immunostaining. Likewise,
practically no signal was detected when the antibodies were
preincubated with their corresponding antigen peptide (Fig.
1Bb,d,f), demonstrating that the staining shown in panels a,
c, and e is speci¢c.
Consistent with the expression of di¡erent CaV3 proteins,
the dose^response analysis for Ni2þ blockade performed on
native Ca2þ currents in mouse spermatogenic cells revealed
the presence of subtypes of low-threshold channels. Represen-
tative whole-cell patch-clamp recordings (Fig. 1C, upper pan-
el) indicated that the IC50 for Ni2þ blockade was V21 WM
(Fig. 1C, lower panel). In contrast, as reported by Lee and
colleagues [24], the Ni2þ IC50 for CaV3.2 is V12 WM and the
IC50 values determined for CaV3.1 and CaV3.3 are V20-fold
higher. Considering the data in recombinant channels, the
potency of Ni2þ in spermatogenic cells is intermediate. These
results, analyzed as indicated by Lee et al. [24], suggest that
the native current may arise from the activity of di¡erent
types of low-threshold channels, with CaV3.2 contributing
around 60%.
We next examined the expression of CaV3 channels in ma-
ture mouse sperm. Although our results for CaV3.1 were in-
conclusive with the anti-K1G antibody from Santa Cruz, the
use of a new polyclonal anti-CaV3.1 antibody (Alomone Labs)
corroborated speci¢c immunostaining in the head (50% of
sperm) and principal £agellar piece (Fig. 2A). Fig. 2B also
shows illustrative confocal images before (left) and after in-
duction of the sperm AR with a Ca2þ ionophore (right). Panel
Ba illustrates that CaV3.2 immunoreactivity was con¢ned to
the head overlying the acrosome. Upon AR the CaV3.2 signal
did not undergo redistribution and remained associated with
the head. However, this process decreased £uorescence stain-
ing giving a vesiculated pattern (panel Bb) consistent with the
formation of hybrid vesicles [26]. Panel Bc shows that the
CaV3.3 channel is located in the £agellar midpiece and not
in the head or the principal piece of the tail. As anticipated its
distribution was unchanged in acrosome-reacted sperm (panel
Bd). Controls discussed in Section 2 using anti-CaV3 antibod-
ies on HEK-293 cells separately expressing the three CaV3
channel isoforms indicate that the staining illustrated in Fig.
2 is speci¢c.
Thereafter we sought to determine the expression of T-type
channels in human sperm. As in the case of mouse sperm,
expression of CaV3.1 in human sperm could not be con¢-
dently determined with the Santa Cruz antibody since immu-
nostaining was not fully blocked by the corresponding antigen
peptide. However, anti-CaV3.1 from Alomone gave speci¢c
binding in the head as well as in the mid and principal pieces
of the tail (Fig. 3Aa). The CaV3.2 antibody recognized the
principal piece with an intense punctate signal and excluded
Fig. 1. CaV3 proteins are expressed in spermatogenic cells. A: RNA was extracted from spermatogenic cells and subjected to RT-PCR with
speci¢c primers based on the sequence of CaV3.3. Lanes 2^4 show PCR products generated from mouse testis (T), pachytene spermatocytes
(PS), and round spermatids (RS), respectively. Lane 5 is a negative control (3). The product was sequenced to verify speci¢c ampli¢cation.
Molecular weights of the standards are shown on the left. B: Representative confocal micrographs from cells immunostained with CaV3.1 (a),
CaV3.2 (c) and CaV3.3 (e) channel antibodies, showing the cluster arrangement of the proteins (red), or stained with the anti-CaV3 antibodies
preincubated with the corresponding antigen peptide to demonstrate that speci¢c staining is blocked by the peptide (b, d, and f); nuclei are
shown in green. C: Representative superimposed whole-cell patch-clamp Ca2þ current traces activated in mouse spermatogenic cells by 200 ms
pulses to 320 mV from a holding potential of 390 mV (upper panel) before and after application of 35 WM and 1 mM Ni2þ. The lower panel
shows the dose^response analysis of Ni2þ blockade. Following exposure to the indicated concentration of the inhibitor, peak current amplitude
was normalized to the control. The percentage of inhibition is compared with that obtained from HEK-293 cells expressing CaV3.1, CaV3.2 or
CaV3.3. Smooth curves were generated with the Hill equation according to the parameters reported from currents through the cloned channels
[24]. (For interpretation of the references to color in this ¢gure legend, the reader is referred to the web version of this article.)
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the end piece of the £agellum (Fig. 3Ab). In addition, a faint
CaV3.2 immuno£uorescent signal was noted in the base of the
human sperm head. On the other hand, the £uorescent signal
for CaV3.3 (N-terminal antibody) was restricted to the mid-
piece of the £agellum (as in mouse sperm) (Fig. 3Ac). Binding
of the CaV3 antibodies was competed only by the correspond-
ing peptide antigen but not by the other peptides (not shown),
thus indicating their speci¢city. To our knowledge this is the
¢rst evidence for the localization of CaV3 channels in human
sperm.
CaV3 protein expression and localization in human sperm
was corroborated using transmission electron microscopy. Ul-
trathin sections from embedded cells were incubated with the
CaV3 antibodies followed by a secondary antibody conjugated
to colloidal gold. Control sections showed only background
levels of gold particles with no speci¢c sperm localization. The
micrographs in Fig. 3B show that gold particles were prefer-
entially associated with tail plasma membrane, less in the head
and rarely in the cell interior. The lower abundance of CaV
channel in the head and speci¢cally CaV3.1 found with this
technique may help to explain our di⁄culty to detect these
channels by immuno£uorescence.
Given that CaV3 channels are present in the human sperm
£agella, we tested whether two T-type channel inhibitors, mi-
befradil [11,27,28] and gossypol [18], in£uence motility. To
this end, a post-swim-up sperm suspension was diluted in cul-
ture medium in the absence or presence of di¡erent concen-
trations of the channel antagonists and motility was analyzed
using CASA. Interestingly, concentrations of these two com-
pounds that inhibit CaV3 channels only reduced basal motility
by 6 3% after 1 min, in agreement with our previous ¢ndings
with low Ni2þ concentrations (50 WM) that block these chan-
nels [19]. These observations indicate that CaV3 channels es-
sentially do not in£uence the basal motility of human sperm.
However, higher doses of mibefradil (30 WM) and gossypol
(40 WM) that block HVA channels decreased human sperm
velocity parameters making their trajectories less progressive
(Table 1). These results may explain, at least in part, why
Fig. 2. CaV3 proteins are expressed and di¡erentially localized in mouse epididymal sperm. Cells were attached to glass slides, and subjected to
indirect immuno£uorescence. A: Shown are confocal immuno£uorescence images of mature sperm stained with anti-CaV3.1 antibodies (panel
a). Panel b shows the corresponding phase contrast image. B: CaV3 confocal immuno£uorescence images in mouse sperm before and after
undergoing the AR. Paired phase contrast (inset) and £uorescence micrographs of anti-CaV3.2 and CaV3.3 in acrosome-intact (a, c) and acro-
some-reacted sperm (b, d). Nuclei are shown in green. (For interpretation of the references to color in this ¢gure legend, the reader is referred
to the web version of this article.)
Table 1
E¡ects of CaV channel antagonists on human sperm motility
CASA parameter Mibefradil 30 WM
(% inhibition)
Gossypol 40 WM
(% inhibition)
Basal motility 25X 8 21X 6
VAP 33X 9 23X 6
VSL 31X 10 27X 5
VCL 31X 5 13X 8
Data are expressed as meanXS.E.M. (n=3^8 separate determina-
tions; three di¡erent donors).
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Fig. 3. CaV3 proteins are di¡erentially expressed in human sperm. A: Representative confocal micrographs from cells stained with CaV3.1- (a),
CaV3.2- (b) and CaV3.3- (c) speci¢c antibodies showing the immuno£uorescence localization of the proteins. Insets represent the corresponding
phase contrast images. B: Immunogold electron microscopy detected CaV3 channels in human sperm. Ultrathin sections of human sperm were
incubated with CaV3.1 (a), CaV3.2 (b) and CaV3.3 (c) antibodies. Gold particles (arrows) are associated with the plasma membrane of the
sperm head (left panel of each ¢gure). In longitudinal £agellar sections, gold labeling is observed associated with the plasma membrane as well
as in the ribs of the ¢brous sheath at the principal piece (right panel of each ¢gure). CaV3.3 antibody labeled the mitochondrial sheath at the
midpiece of the £agellum (c). Scale bar= 0.5 Wm.
Fig. 4. CaV1.2 and CaV2.3 channels are present in human sperm. Representative confocal micrographs from sperm cells immunostained with
CaV1.2 antibodies (a) showing strong speci¢c staining at the mid and the end pieces of the tail, as well as with CaV2.3 antibodies (c) showing
signal in the principal piece of the £agellum and the equatorial segment of sperm head. Panels b and d are control experiments in which the
antibodies were preincubated with the corresponding antigen peptide to demonstrate speci¢city.
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gossypol and possibly mibefradil, like other CaV channel an-
tagonists, can a¡ect human sperm fertilizing ability [29,30].
The previous results also suggest the possible presence of
HVA channels in human sperm. CaV1.2 and CaV2.1 are
present in the tail of mouse sperm [21,22,31] and CaV1.2 in
the acrosomal region of human sperm [32]. In our hands,
speci¢c antibodies for these channels revealed positive immu-
nostaining for CaV1.2 strong in the midpiece and less intense
in the principal piece (Fig. 4a), and for CaV2.3 in the principal
piece and the equatorial segment of the head (Fig. 4b). Anti-
bodies against CaV1.3, CaV2.1 and CaV2.2 did not produce
speci¢c signals. In spite of the presence of HVA channels in
the human sperm £agella, two other blockers of CaV1 chan-
nels, nifedipine (up to 20 WM) and calciseptine (up to 5 WM)
[33], did not signi¢cantly a¡ect motility, ruling out an impor-
tant role of CaV1 channels in this function. On the other
hand, recently it was reported that a transgenic mouse lacking
CaV2.3 had motility alterations [34].
In conclusion, we identi¢ed the expression of CaV3.3
mRNA in mouse male germ cells, an isoform not previously
described in these cells. This study also provides what is to
our knowledge the ¢rst evidence that all three types of CaV3
channels are detected in male germ cells and display di¡er-
ential distribution in sperm. After di¡erentiation and matura-
tion CaV3.1 and CaV3.2 channels are present on the mouse
sperm head, indicating that they may participate in regulating
acrosomal exocytosis. Recently mice de¢cient in CaV3.2 were
found to be fertile, which suggests CaV3.1 might be enough to
allow the sperm AR [36]. Interestingly, CaV3 channel activity,
particularly CaV3.2, has been associated with the AR in hu-
man sperm [14,35]. Likewise, tail localization of CaV3 chan-
nels suggested they may in£uence sperm motility. This was
also the case for CaV1.2 and CaV2.3 channels. However,
blockers of CaV1 and CaV3 channels did not signi¢cantly
a¡ect basal motility, indicating they do not play a major
role in this sperm function. The possibility that these channels
participate in hyperactivated motility, as Catsper does [21],
cannot be ruled out.
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